Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists

Suicide Clinical Trial

Official title:

Role of Pharmacists in Suicide Prevention: Needs Assessment Among Pharmacists

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05580757
• Other study ID #: ONZ-2022-0233
• Status: Completed
• Start date: September 2, 2022
• Est. completion date: December 8, 2022

Study information

• Verified date: January 2023
• Source: University Ghent
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to examine the opinions and needs of pharmacists and pharmaceutical technical assistants (FTA) concerning their role as gatekeepers in suicide prevention.

The primary objective is to map the experiences and needs of (public) pharmacists and FTA with regard to suicide prevention.

The secondary objective is to be able to develop more targeted tools, interventions or trainings based on the results of the needs assessment in order to facilitate the role of (public) pharmacists and FTA as gatekeepers in suicide prevention.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 118
• Est. completion date: December 8, 2022
• Est. primary completion date: December 8, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Working as a (public) pharmacist or pharmaceutical technical assistant (FTA)

• 18 years or older

• Access to a computer, tablet or mobile phone with internet access

• Dutch-speaking

Exclusion Criteria:

• Hospital pharmacists or industrial pharmacists are not included in this study and thus constitute an exclusion criterion.

Related Conditions & MeSH terms

• Pharmacist-Patient Relations
• Suicidal Ideation
• Suicide
• Suicide, Attempted

Locations

Country	Name	City	State
Belgium	Flemish Centre of Expertise in Suicide Prevention, Ghent University	Ghent

Sponsors (1)

Lead Sponsor	Collaborator
University Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Needs	Questionnaire based on a study by Gillette et al. (2020), scientific literature and previous needs surveys conducted by VLESP. In collaboration with the Flemish Pharmacists Network.; Socio-demographics; Perceptions, attitudes and barriers: 55 statements (completely disagree, disagree, neutral, agree, completely agree); Contact with suicidal person (never/rarely, few times a year, monthly, weekly, daily), experience (very un-, rather un-, neutral, experienced, very experienced), possible actions as gatekeeper, referral, known organizations/helplines, previous education (yes or no), knowledge (yes/no)/ satisfaction (not at all, rather not, neutral, rather, very) existing education; Preparedness/need training (not at all, rather not, neutral, rather, very), preferred format of training, needed information; Suicidal thoughts/attempts (yes/no), hopelessness: 4 items (true/false)	Baseline. Completing the questionnaire will take approximately 15-20 minutes.